Lippincott Williams & Wilkins (LWW): Hepatology Journal: Published on May, 2023This new American Association for the Study of Liver Diseases (AASLD) Guidance document reflects many advances in the field pertinent to any practitioner caring for patients with NAFLD and emphasizes advances in noninvasive risk stratification and therapeutics.The mo...

AACE Endocrine Practice Journal: Published on May, 2022Nonalcoholic fatty liver disease (NAFLD) is part of a multisystemic disease and is closely associated with obesity, insulin resistance (IR), type 2 diabetes mellitus (T2D), hypertension, and atherogenic dyslipidemia. The definition of NAFLD is based on the presence of hepatic steatosis in...

AACE Endocrine Practice Journal: Published on May, 2022Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease affecting 25% of the global population. NAFLD is associated with cardiometabolic disorders: (1) obesity, (2) insulin resistance, (3) type 2 diabetes mellitus, (4) high blood pressure, and (5) at...